Topic
Immune Checkpoint Inhibitors
20 Podcasts • 8 Cases • 4 Courses on BackTable
Episode # 84 • 06 Oct 2026
Managing Refractory MSS-MCRC: Advanced Treatment Strategies
What options remain when a patient with microsatellite stable metastatic colorectal cancer (MSS mCRC) has progressed through every standard line of chemotherapy? On this episode of BackTable Tumor Board, Dr. Jun Gong is joined by Dr. Ibrahim Sahin and Dr. Sandra Algaze to explore the nuances of late-line management in MSS-mCRC. They discuss how to approach oxaliplatin retreatment and anti-EGFR rechallenge, the growing role of liquid biopsy and biomarker-driven selection, and the practicalities of DPYD testing after recent guideline changes.
More on Immune Checkpoint Inhibitors
Loading recent podcasts …
Tumor Board # 84
Oct 5, 2026
with Dr. Ibrahim Sahin, Dr. Sandra Algaze, Dr. Jun Gong
What options remain when a patient with microsatellite stable metastatic colorectal cancer (MSS mCRC) has progressed...
Tumor Board # 75
Aug 3, 2026
with Dr. Cathy Eng, Dr. Jun Gong
Is it time to rethink the definition of “cure” for stage IV colorectal cancer? In this episode of BackTable Tumor...
1,800+ listens
Vascular & IR # 647
May 20, 2026
with Dr. Juan Gimenez, Dr. Ari Cohen, Dr. Jonathan Mizrahi
In treating hepatocellular carcinoma (HCC), the hardest question often isn’t which treatment to use, it’s who should...
Vascular & IR # 622
Mar 4, 2026
with Dr. Jennifer McQuade, Dr. Rahul Sheth, Dr. Tyler Sandow
When standard-of-care checkpoint blockade fails in metastatic melanoma, how can oncologists and interventional...
1,400+ listens
Tumor Board # 83
Sep 28, 2026
with Dr. Sandra Algaze, Dr. Ibrahim Sahin, Dr. Jun Gong
Which molecular alterations in colorectal cancer now change treatment and how quickly do you need the results to make...
Vascular & IR # 659
Jun 29, 2026
with Dr. Beau Toskich, Dr. Lingling Du, Dr. Tyler Sandow
How do you safely combine locoregional and systemic therapies to treat hepatocellular carcinoma (HCC) when traditional...
1,400+ listens
Tumor Board # 51
Mar 16, 2026
with Dr. Jennifer McQuade, Dr. Rahul Sheth, Dr. Tyler Sandow
When standard-of-care checkpoint blockade fails in metastatic melanoma, how can oncologists and interventional...
Tumor Board # 46
Feb 2, 2026
with Dr. William Moore, Dr. Daniel Sterman, Dr. Ben Cooper
Pulsed electric field (PEF) therapy is an emerging cancer treatment that utilizes short electrical pulses to disrupt...
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Urology Case
Jun 9, 2025
with Dr. Jeannie Hoffman-Censits, Dr. Bogdana Schmidt and Dr. Nirmish Singla
Urology Case
Jun 9, 2025
with Dr. Jeannie Hoffman-Censits, Dr. Bogdana Schmidt and Dr. Nirmish Singla
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Urology Case
Jun 9, 2025
with Dr. Jeannie Hoffman-Censits, Dr. Bogdana Schmidt and Dr. Nirmish Singla
Urology Case
Jun 9, 2025
with Dr. Jeannie Hoffman-Censits, Dr. Bogdana Schmidt and Dr. Nirmish Singla
Urology Course
3 hours, 28 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.